DDIS-25. PENTAMIDINE; A NEW CHEMOTHERAPY TARGETING ON GLIOMA STEM LIKE CELLS

INTRODUCTION: Glioblastoma (GBM) is the most common primary malignant brain tumors. Despite aggressive therapies, median overall survival of patients who suffered from GBM is only 18 months. Furthermore, there is no effective therapy for glioma stem cells (GSCs), which act as forming tumors. Herein,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Tamai, Sho, Jiapaer, Shabierjiang, Zhang, Guangtao, Zhang, Jiakang, Wang, Yi, Sabit, Hemragul, Tanaka, Shingo, Kinoshita, Masashi, Hirao, Atsushi, Nakada, Mitsutoshi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2019
Onderwerpen:
Drug Discovery
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847863/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.276
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items